CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Zydus Pharmaceuticals (USA) Inc recalls Succinylcholine Chloride…

Zydus Pharmaceuticals (USA) Inc recalls Succinylcholine Chloride Injection

Read the official FDA notice

Published
17 Sept 2025
Units affected
270,125 Vials
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1377-1 (vial), NDC 70710-1377-2 (carton).

Brand / company
Zydus Pharmaceuticals (USA) Inc
Codes / lots
Lot #s: L400077, exp: 8/31/2025; L400113, exp.: 9/30/2025; L400372, L400373, exp.: 3/31/2026; L400374, exp.: 4/30/2026.
Distribution
MS, OH, LA, and Puerto Rico
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 17 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.